Abstract
(Chemical Presented) A potential anti-SARS drug has been developed by dynamic ligation screening (DLS), by which nucleophilic fragments are directed to the protein's active site by reversible reaction with an aldehyde inhibitor. Their inhibitory effect is detected by competition with a fluorogenic enzyme substrate. With this concept, low-affinity fragments binding specifically to the active site are quickly identified in a functional enzyme assay.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Angewandte Chemie - International Edition |
| Jahrgang | 47 |
| Ausgabenummer | 17 |
| Seiten (von - bis) | 3275-3278 |
| Seitenumfang | 4 |
| ISSN | 1433-7851 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 14.04.2008 |
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)
Coronavirus-Bezug
- Forschung zu SARS-CoV-2 / COVID-19